J. B. Chemicals & Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 5/6
J. B. Chemicals & Pharmaceuticals has a total shareholder equity of ₹27.2B and total debt of ₹4.5B, which brings its debt-to-equity ratio to 16.6%. Its total assets and total liabilities are ₹38.0B and ₹10.8B respectively. J. B. Chemicals & Pharmaceuticals's EBIT is ₹7.4B making its interest coverage ratio 16.5. It has cash and short-term investments of ₹3.9B.
Key information
16.6%
Debt to equity ratio
₹4.50b
Debt
Interest coverage ratio | 16.5x |
Cash | ₹3.93b |
Equity | ₹27.17b |
Total liabilities | ₹10.82b |
Total assets | ₹37.99b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 506943's short term assets (₹17.6B) exceed its short term liabilities (₹6.4B).
Long Term Liabilities: 506943's short term assets (₹17.6B) exceed its long term liabilities (₹4.4B).
Debt to Equity History and Analysis
Debt Level: 506943's net debt to equity ratio (2.1%) is considered satisfactory.
Reducing Debt: 506943's debt to equity ratio has increased from 1.8% to 16.6% over the past 5 years.
Debt Coverage: 506943's debt is well covered by operating cash flow (170.5%).
Interest Coverage: 506943's interest payments on its debt are well covered by EBIT (16.5x coverage).